Wegovy is approved specifically for obesity management, yet Ozempic, approved for diabetes management, appears to be more popular (Han et al
(2022) [59] comparing GLP-1RA plus SGLT2i combination therapy to GLP-1RA and SGLT2i monotherapies among 1,895 patients with T2DM enrolled in 8 RCTs, the addition of a GLP-1RA to SGLT2i treatment showed that drug discontinuation, diarrhea, injection-site-related events, nausea, vomiting and genital infections were more likely to occur in combination therapy
In cooperation with our compounding pharmacy partners, DrWell is now able to offer compounded medication that combines semaglutide and tirzepatide, GLP-12, if your prescriber determines it is medically necessary during a visit
Food Chem Toxicol 45:15511557 Ramos-Tovar E, Muriel P (2020) Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver